The ICR responds to decision by NICE not to recommend pembrolizumab as first-line treatment for advanced head and neck cancer 15 Jan 2020
Major trial backs immunotherapy as standard first-line treatment for head and neck cancer 23 Nov 2019
ICR alumnus Professor Jacques Miller wins prestigious Albert Lasker Award for pioneering research underpinning modern immunology 10 Sep 2019